Mainit, Arnold L.
HRN: 25-16-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/07/2024
06/13/2024
IVT
600mg
Q6
Sepsis Sec To NIFU Sec To PAOD Vs DM Type II
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes